Dexamethasone Sodium Phosphate recalls
Dexamethasone Sodium Phosphate products have been recalled 4 times, most recently on 25 Mar 2026. The recalling company is usually West-Ward Pharmaceuticals. The most common reason is potency & assay.
Total recalls4since 2017
Last 12 months1reported
Class I00% of total
Ongoing2latest 25 Mar 2026
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 50%Class III 2 50%
Why dexamethasone sodium phosphate is recalled
Companies
Product types
By year
Ongoing dexamethasone sodium phosphate recalls
2 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Dexamethasone Sodium Phosphate Injection, USP, 100 mg recalledDexamethasone Sodium Phosphate | Somerset Therapeutics | Potency & Assay | Nationwide |
| Drug | CLASS II | Dexamethasone Sodium Phosphate injection USP, 120mg recalled by Eugia USDexamethasone Sodium Phosphate | Eugia US | Potency & Assay | Nationwide |
All dexamethasone sodium phosphate recalls, newest first
4 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Dexamethasone Sodium Phosphate Injection, USP, 100 mg recalledDexamethasone Sodium Phosphate | Somerset Therapeutics | Potency & Assay | Nationwide |
| Drug | CLASS II | Dexamethasone Sodium Phosphate injection USP, 120mg recalled by Eugia USDexamethasone Sodium Phosphate | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS III | Dexamethasone Sodium Phosphate Injection, USP, 20 mg recalledDexamethasone Sodium Phosphate | West-Ward Pharmaceuticals | Potency & Assay | Nationwide |
| Drug | CLASS III | Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL Vials recalledDexamethasone Sodium Phosphate | West-Ward Pharmaceuticals | Potency & Assay | Nationwide |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.